Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of NaV1.8 in Human Pain Models - a Randomized, Placebo-controlled Crossover Microdosing Trial

NCT07511400 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT07511400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of NaV1.8 in Human Pain Models - a Randomized, Placebo-controlled Crossover Microdosing Trial
Lead sponsor
Medical University of Vienna
Phase
Phase 1
Overall status
Completed
Start date
April 21, 2026
Completion date
June 9, 2026
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, healthy volunteer study, pain